Shaping Markets

The past decade has been witness to some remarkable advances in increasing access to a wide range of affordable quality medicines and health supplies.  In the case of vaccines and anti-retroviral drugs, for example, market interventions and greater market competition have yielded millions of dollars in cost savings; while in the family planning sphere, innovating financing mechanisms, volume guarantees, and expansion of a quality assured supplier base have increased access to a range of contraceptives, including injectables, implants and female condoms.

Efforts such as these illustrate the power of the market to determine health outcomes. They also illustrate the potential of the reproductive health community to consciously, but wisely, shape what goes on in the market—be it through leveraging purchasing power, increasing access to market data, incentivizing new entrants into the marketplace, or simply through eliminating policy barriers.

What will the Coalition do?

The Coalition has established a solid track record in assembling the brain trust and creating the neutral space required for candid market-based discussions and interventions. Looking ahead, the Coalition will leverage that capacity as it seeks to reduce information gaps, disseminate critical data about the market and facilitate discussions with key stakeholders. We are also committed to enhancing market efficiency by reducing barriers to entry and optimizing procurement practices. Join us as we seek to:

  • Document and make sense of the diversity of market initiatives currently underway to improve health outcomes, especially in the areas of choice, equity and impact.
  • Deliver needed market data by reducing information gaps and by facilitating discussions with manufacturers on key issues such as price, quality, production volumes, market entry, and registration.
  • Explore new opportunities to assess market demand through better consumption data, globally and at country level.
  • Expand opportunities for innovative financing of reproductive health commodities